J.&J. will resume its Europe vaccine rollout after the E.U.’s regulator says the shot should carry a label.
- The move came after the E.U.’s drug regulator said the Johnson & Johnson vaccine should carry a warning for a potential risk for rare blood clots, though the agency said it believes the shot’s benefits outweigh risks.
According to an article published in The New York Times, Johnson & Johnson said Tuesday that it would resume the rollout of its coronavirus vaccine in Europe after the...
https://mfame.guru/jj-vaccines-back-to-rollout-outweighing-risks-in-europe/